| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity | 3.95e-05 | 3 | 73 | 2 | GO:0016263 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.43e-04 | 739 | 73 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 4.67e-04 | 9 | 73 | 2 | GO:0070016 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 6.08e-07 | 85 | 75 | 6 | GO:0000118 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOR2 PHC3 SATB2 TCF7L2 OGT ING3 GTF2A1L BCLAF1 BRD4 TET1 AHR CSTF1 POM121L2 MCM7 KMT2E CDC27 HCFC1 | 5.76e-06 | 1377 | 75 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear chromosome | 3.54e-05 | 254 | 75 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 1.26e-04 | 5 | 75 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | chromatin | NCOR2 SATB2 TCF7L2 OGT ING3 FOXN4 BRD4 BARHL2 TET1 AHR ID2 MCM7 IPO4 KMT2E HCFC1 | 2.10e-04 | 1480 | 75 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 5.65e-04 | 45 | 75 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | NSL complex | 6.84e-04 | 11 | 75 | 2 | GO:0044545 | |
| GeneOntologyCellularComponent | basement membrane | 9.75e-04 | 122 | 75 | 4 | GO:0005604 | |
| MousePheno | abnormal nasal bone morphology | 7.95e-06 | 69 | 56 | 5 | MP:0000102 | |
| MousePheno | abnormal cranium morphology | AMELY SPRY2 FRAS1 SATB2 TCF7L2 OGT FOXN4 BRD4 TET1 PFAS EPS8L3 MBD5 HCFC1 | 1.45e-05 | 813 | 56 | 13 | MP:0000438 |
| MousePheno | abnormal nose morphology | 1.46e-05 | 201 | 56 | 7 | MP:0002233 | |
| MousePheno | abnormal craniofacial bone morphology | AMELY SPRY2 FRAS1 SATB2 TCF7L2 OGT FOXN4 BRD4 TET1 PFAS EPS8L3 MBD5 HCFC1 | 1.74e-05 | 827 | 56 | 13 | MP:0002116 |
| MousePheno | abnormal viscerocranium morphology | AMELY SPRY2 FRAS1 SATB2 FOXN4 BRD4 TET1 PFAS EPS8L3 MBD5 HCFC1 | 1.91e-05 | 593 | 56 | 11 | MP:0005274 |
| MousePheno | complete cleft palate | 1.56e-04 | 5 | 56 | 2 | MP:0021213 | |
| MousePheno | abnormal interfrontal bone morphology | 1.56e-04 | 5 | 56 | 2 | MP:0008818 | |
| MousePheno | upturned snout | 2.34e-04 | 6 | 56 | 2 | MP:0006411 | |
| MousePheno | abnormal craniofacial morphology | AMELY NCOR2 SPRY2 FRAS1 SATB2 TCF7L2 OGT FOXN4 BRD4 TET1 PFAS EPS8L3 LRBA MBD5 HCFC1 | 2.35e-04 | 1372 | 56 | 15 | MP:0000428 |
| MousePheno | craniofacial phenotype | AMELY NCOR2 SPRY2 FRAS1 SATB2 TCF7L2 OGT FOXN4 BRD4 TET1 PFAS EPS8L3 LRBA MBD5 HCFC1 | 2.35e-04 | 1372 | 56 | 15 | MP:0005382 |
| MousePheno | abnormal maxilla morphology | 2.71e-04 | 144 | 56 | 5 | MP:0000455 | |
| MousePheno | abnormal spermiation | 2.78e-04 | 32 | 56 | 3 | MP:0004182 | |
| Domain | LRRC37AB_C | 2.48e-07 | 4 | 75 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.48e-07 | 4 | 75 | 3 | IPR032754 | |
| Domain | LRRC37AB_C | 2.48e-07 | 4 | 75 | 3 | IPR029423 | |
| Domain | LRRC37 | 2.48e-07 | 4 | 75 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.48e-07 | 4 | 75 | 3 | IPR015753 | |
| Domain | TCRP1 | 1.59e-05 | 2 | 75 | 2 | PF14944 | |
| Domain | FAM168A/MANI | 1.59e-05 | 2 | 75 | 2 | IPR029247 | |
| Domain | CaMKII_AD | 9.50e-05 | 4 | 75 | 2 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 9.50e-05 | 4 | 75 | 2 | IPR013543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 1.29e-06 | 26 | 45 | 4 | M47923 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.41e-04 | 32 | 45 | 3 | M27900 | |
| Pubmed | NCOR2 PHC3 SATB2 RAPGEF6 OGT ZNF608 MYCBP2 CAMK2G BRD4 TET1 MCM7 LRBA BIRC6 | 8.31e-12 | 418 | 77 | 13 | 34709266 | |
| Pubmed | RAPGEF6 OGT SND1 MYCBP2 BCLAF1 BRD4 TET1 MCM7 LRBA ERBIN HCFC1 | 3.58e-08 | 549 | 77 | 11 | 38280479 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOR2 PHC3 ZNF469 USF3 TCF7L2 RAPGEF6 ING3 SPATA31E1 ITSN1 KMT2E | 3.94e-08 | 430 | 77 | 10 | 35044719 |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 23629655 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 23352454 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22419166 | ||
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 1.24e-06 | 10 | 77 | 3 | 32669118 | |
| Pubmed | 1.24e-06 | 10 | 77 | 3 | 23064749 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.67e-06 | 411 | 77 | 8 | 35182466 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOR2 BEST1 USF3 TCF7L2 OGT FAM168A ZNF608 MYCBP2 PCDH11Y LRBA MBD5 ERBIN SH3RF3 NLK | 4.38e-06 | 1489 | 77 | 14 | 28611215 |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21285374 | ||
| Pubmed | HCF-1 is cleaved in the active site of O-GlcNAc transferase. | 4.84e-06 | 2 | 77 | 2 | 24311690 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25966365 | ||
| Pubmed | The novel protein MANI modulates neurogenesis and neurite-cone growth. | 4.84e-06 | 2 | 77 | 2 | 20716133 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26305326 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17189292 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22883232 | ||
| Pubmed | O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1. | 4.84e-06 | 2 | 77 | 2 | 21295698 | |
| Pubmed | The Biochemistry of O-GlcNAc Transferase: Which Functions Make It Essential in Mammalian Cells? | 4.84e-06 | 2 | 77 | 2 | 27294441 | |
| Pubmed | Hematopoietic stem cell transplantation without irradiation. | 4.84e-06 | 2 | 77 | 2 | 19270698 | |
| Pubmed | CaMKII is essential for the function of the enteric nervous system. | 4.84e-06 | 2 | 77 | 2 | 22952977 | |
| Pubmed | Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor. | 4.84e-06 | 2 | 77 | 2 | 15325265 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23729667 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31089182 | ||
| Pubmed | Livebearing or egg-laying mammals: 27 decisive nucleotides of FAM168. | 4.84e-06 | 2 | 77 | 2 | 28381702 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26823848 | ||
| Pubmed | Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. | 4.98e-06 | 111 | 77 | 5 | 32683582 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOR2 SPRY2 FRAS1 RAPGEF6 SND1 MYCBP2 BRD4 PFAS LRBA MBD5 BIRC6 HCFC1 | 5.47e-06 | 1105 | 77 | 12 | 35748872 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.17e-06 | 203 | 77 | 6 | 22083510 | |
| Pubmed | NCOR2 STRN3 OGT MYCBP2 BCLAF1 PATZ1 CAMK2A CAMK2G ITSN1 IPO4 ERBIN | 8.74e-06 | 963 | 77 | 11 | 28671696 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | NCOR2 TCF7L2 ING3 ZNF608 BCLAF1 CAMK2G BRD4 SDF2L1 MCM7 KMT2E HCFC1 NLK | 1.28e-05 | 1203 | 77 | 12 | 29180619 |
| Pubmed | CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. | 1.45e-05 | 3 | 77 | 2 | 23502535 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 21454679 | ||
| Pubmed | CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair. | 1.45e-05 | 3 | 77 | 2 | 31481791 | |
| Pubmed | Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. | 1.45e-05 | 3 | 77 | 2 | 29662175 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 25246560 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 37879498 | ||
| Pubmed | The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway. | 1.45e-05 | 3 | 77 | 2 | 20141612 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 10347170 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 33050986 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 34685658 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 23516528 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 22158968 | ||
| Pubmed | Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo. | 1.45e-05 | 3 | 77 | 2 | 12554746 | |
| Pubmed | The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism. | 1.45e-05 | 3 | 77 | 2 | 16480812 | |
| Pubmed | Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase. | 1.45e-05 | 3 | 77 | 2 | 1309762 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 24216759 | ||
| Pubmed | Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. | 1.45e-05 | 3 | 77 | 2 | 19603549 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 9882483 | ||
| Pubmed | Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. | 2.89e-05 | 4 | 77 | 2 | 22503562 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 20200153 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 10395741 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 12556497 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 24394411 | ||
| Pubmed | DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4. | 2.89e-05 | 4 | 77 | 2 | 30057199 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 10381553 | ||
| Pubmed | TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. | 2.89e-05 | 4 | 77 | 2 | 23353889 | |
| Pubmed | BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5. | 2.89e-05 | 4 | 77 | 2 | 26419610 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 25568311 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 2.89e-05 | 4 | 77 | 2 | 17367784 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 12139968 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 11889801 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.95e-05 | 398 | 77 | 7 | 35016035 | |
| Pubmed | NCOR2 SATB2 TCF7L2 OGT SND1 MYCBP2 BCLAF1 CAMK2G BRD4 MCM7 HCFC1 | 3.06e-05 | 1103 | 77 | 11 | 34189442 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 3.41e-05 | 560 | 77 | 8 | 21653829 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 4.49e-05 | 31 | 77 | 3 | 25838543 | |
| Pubmed | 4.49e-05 | 31 | 77 | 3 | 27321927 | ||
| Pubmed | 4.49e-05 | 31 | 77 | 3 | 26678539 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 11160423 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 11013247 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 19671701 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 29466738 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 8663317 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 18218981 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 21209221 | ||
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 4.82e-05 | 5 | 77 | 2 | 28636948 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 14722083 | ||
| Pubmed | O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1. | 4.82e-05 | 5 | 77 | 2 | 29941490 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 12486117 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 4.82e-05 | 5 | 77 | 2 | 16436603 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 34667079 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.34e-05 | 774 | 77 | 9 | 15302935 | |
| Pubmed | 6.49e-05 | 35 | 77 | 3 | 22991445 | ||
| Pubmed | 6.80e-05 | 191 | 77 | 5 | 24146773 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 16714285 | ||
| Pubmed | TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator. | 7.22e-05 | 6 | 77 | 2 | 25517638 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 7.22e-05 | 6 | 77 | 2 | 18948074 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 16120608 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 24703950 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 11027280 | ||
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 7.22e-05 | 6 | 77 | 2 | 11972023 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 27506116 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.38e-05 | 1005 | 77 | 10 | 19615732 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | OGT SND1 MYCBP2 CAMK2G CSTF1 PFAS MCM7 IPO4 CDC27 BIRC6 HCFC1 | 9.88e-05 | 1257 | 77 | 11 | 37317656 |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 34932950 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 30069701 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 22072767 | ||
| Pubmed | A role for SKIP in EBNA2 activation of CBF1-repressed promoters. | 1.01e-04 | 7 | 77 | 2 | 10644367 | |
| Pubmed | Enamel-free teeth: Tbx1 deletion affects amelogenesis in rodent incisors. | 1.01e-04 | 7 | 77 | 2 | 19233155 | |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 1.01e-04 | 7 | 77 | 2 | 9115241 | |
| Interaction | KDM1A interactions | NCOR2 SPRY2 PHC3 SATB2 RAPGEF6 OGT ZNF608 MYCBP2 CAMK2G BRD4 TET1 ID2 MCM7 LRBA BIRC6 PHF21B | 1.58e-07 | 941 | 72 | 16 | int:KDM1A |
| Interaction | HDAC1 interactions | NCOR2 SATB2 TCF7L2 RAPGEF6 OGT ZNF608 MYCBP2 CAMK2G BRD4 TET1 MCM7 LRBA KMT2E BIRC6 HCFC1 PHF21B | 1.40e-06 | 1108 | 72 | 16 | int:HDAC1 |
| Interaction | FAM168B interactions | 2.00e-06 | 58 | 72 | 5 | int:FAM168B | |
| Interaction | EGLN3 interactions | NCOR2 SPRY2 OGT FAM168B FAM168A MYCBP2 FOXN4 BRD4 AHR SDF2L1 PFAS MCM7 IPO4 CDC27 BIRC6 ERBIN HCFC1 | 2.29e-06 | 1296 | 72 | 17 | int:EGLN3 |
| Interaction | TBR1 interactions | 3.14e-06 | 113 | 72 | 6 | int:TBR1 | |
| Interaction | PHF21A interactions | 3.58e-06 | 343 | 72 | 9 | int:PHF21A | |
| Interaction | ASXL1 interactions | 8.13e-06 | 286 | 72 | 8 | int:ASXL1 | |
| Interaction | SIN3A interactions | 8.18e-06 | 380 | 72 | 9 | int:SIN3A | |
| Interaction | RCOR1 interactions | 9.83e-06 | 494 | 72 | 10 | int:RCOR1 | |
| Interaction | KANSL3 interactions | 1.41e-05 | 86 | 72 | 5 | int:KANSL3 | |
| Interaction | WWTR1 interactions | 1.88e-05 | 422 | 72 | 9 | int:WWTR1 | |
| Interaction | FOXI1 interactions | 1.95e-05 | 92 | 72 | 5 | int:FOXI1 | |
| Interaction | CLEC11A interactions | 2.40e-05 | 96 | 72 | 5 | int:CLEC11A | |
| Interaction | FXR1 interactions | NCOR2 SPRY2 SND1 MYCBP2 BCLAF1 CAMK2A CAMK2G BRD4 ITSN1 CCDC92 KAZN | 2.73e-05 | 679 | 72 | 11 | int:FXR1 |
| Interaction | TFCP2L1 interactions | 2.79e-05 | 99 | 72 | 5 | int:TFCP2L1 | |
| Interaction | SAP30 interactions | 2.94e-05 | 167 | 72 | 6 | int:SAP30 | |
| Interaction | CAMK2B interactions | 4.76e-05 | 182 | 72 | 6 | int:CAMK2B | |
| Interaction | HNF1B interactions | 6.05e-05 | 190 | 72 | 6 | int:HNF1B | |
| Interaction | KLF5 interactions | 6.98e-05 | 195 | 72 | 6 | int:KLF5 | |
| Interaction | RNF4 interactions | NCOR2 TCF7L2 ING3 ZNF608 ZNF792 BCLAF1 PATZ1 CAMK2G BRD4 SDF2L1 MCM7 KMT2E BIRC6 HCFC1 NLK | 1.16e-04 | 1412 | 72 | 15 | int:RNF4 |
| Interaction | HCFC1R1 interactions | 1.25e-04 | 5 | 72 | 2 | int:HCFC1R1 | |
| Interaction | SRF interactions | 1.40e-04 | 139 | 72 | 5 | int:SRF | |
| Interaction | TERF2IP interactions | 1.49e-04 | 552 | 72 | 9 | int:TERF2IP | |
| Interaction | AR interactions | NCOR2 TCF7L2 OGT ZNF608 MYCBP2 PATZ1 BRD4 AHR MCM7 IPO4 CDC27 HCFC1 | 1.89e-04 | 992 | 72 | 12 | int:AR |
| Interaction | SOX7 interactions | 2.12e-04 | 82 | 72 | 4 | int:SOX7 | |
| Interaction | RBPMS2 interactions | 2.22e-04 | 83 | 72 | 4 | int:RBPMS2 | |
| Interaction | HDAC2 interactions | NCOR2 SATB2 TCF7L2 OGT MYCBP2 BRD4 TET1 MCM7 LRBA HCFC1 PHF21B | 2.35e-04 | 865 | 72 | 11 | int:HDAC2 |
| Interaction | NPAS1 interactions | 2.43e-04 | 245 | 72 | 6 | int:NPAS1 | |
| Interaction | PAX2 interactions | 2.44e-04 | 85 | 72 | 4 | int:PAX2 | |
| Interaction | LASP1 interactions | 2.54e-04 | 247 | 72 | 6 | int:LASP1 | |
| Interaction | CAMK2N2 interactions | 2.61e-04 | 7 | 72 | 2 | int:CAMK2N2 | |
| Interaction | GSC interactions | 2.66e-04 | 87 | 72 | 4 | int:GSC | |
| Interaction | RBPJ interactions | 2.95e-04 | 254 | 72 | 6 | int:RBPJ | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 8.30e-06 | 467 | 76 | 9 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.10e-05 | 484 | 76 | 9 | MM999 | |
| Coexpression | ZHU_CMV_8_HR_DN | 1.36e-05 | 50 | 76 | 4 | M9806 | |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 2.15e-05 | 115 | 76 | 5 | M40201 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 2.57e-05 | 200 | 76 | 6 | M4817 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 5.70e-05 | 141 | 76 | 5 | M39235 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.67e-05 | 186 | 76 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 189 | 76 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 189 | 76 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 189 | 76 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 192 | 76 | 5 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.99e-05 | 193 | 76 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.20e-05 | 197 | 76 | 5 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.25e-05 | 198 | 76 | 5 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 4.31e-06 | 197 | 76 | 7 | 2763_DN | |
| Disease | glucose measurement | 4.36e-05 | 380 | 73 | 7 | EFO_0004468 | |
| Disease | risky sexual behaviour measurement | 6.37e-05 | 169 | 73 | 5 | EFO_0007877 | |
| Disease | risk-taking behaviour | SPRY2 TCF7L2 GTF2A1L ZNF608 SND1 BARHL2 POM121L2 KMT2E BIRC6 | 1.10e-04 | 764 | 73 | 9 | EFO_0008579 |
| Disease | schizophrenia, type 2 diabetes mellitus | 1.67e-04 | 43 | 73 | 3 | MONDO_0005090, MONDO_0005148 | |
| Disease | R-6-hydroxywarfarin measurement | 1.87e-04 | 114 | 73 | 4 | EFO_0803327 | |
| Disease | Small cell carcinoma of lung | 3.29e-04 | 54 | 73 | 3 | C0149925 | |
| Disease | aspartate aminotransferase measurement | 3.84e-04 | 904 | 73 | 9 | EFO_0004736 | |
| Disease | polychlorinated biphenyls measurement | 5.68e-04 | 65 | 73 | 3 | EFO_0007042 | |
| Disease | chenodeoxycholate measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0010471 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 6.49e-04 | 68 | 73 | 3 | EFO_0007826, EFO_0007860 | |
| Disease | diabetes mellitus | 6.49e-04 | 68 | 73 | 3 | EFO_0000400 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 7.36e-04 | 71 | 73 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | Prostatic Neoplasms | 8.27e-04 | 616 | 73 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.27e-04 | 616 | 73 | 7 | C0376358 | |
| Disease | urate measurement, bone density | 8.51e-04 | 619 | 73 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | vital capacity | 9.05e-04 | 1236 | 73 | 10 | EFO_0004312 | |
| Disease | coffee consumption measurement | 1.09e-03 | 182 | 73 | 4 | EFO_0006781 | |
| Disease | corneal hysteresis | 1.11e-03 | 20 | 73 | 2 | EFO_0010066 | |
| Disease | reaction time measurement | 1.21e-03 | 658 | 73 | 7 | EFO_0008393 | |
| Disease | Abnormality of refraction | 1.38e-03 | 673 | 73 | 7 | HP_0000539 | |
| Disease | chronic obstructive pulmonary disease | 1.56e-03 | 688 | 73 | 7 | EFO_0000341 | |
| Disease | Coronary heart disease | 1.61e-03 | 24 | 73 | 2 | C0010068 | |
| Disease | social interaction measurement | 1.66e-03 | 94 | 73 | 3 | EFO_0009592 | |
| Disease | cortical thickness | 1.67e-03 | 1113 | 73 | 9 | EFO_0004840 | |
| Disease | cortical surface area measurement | SPRY2 STRN3 ZNF469 SATB2 TCF7L2 GLS2 FAM168A SND1 MYCBP2 SH3RF3 | 1.70e-03 | 1345 | 73 | 10 | EFO_0010736 |
| Disease | cerebral amyloid deposition measurement | 1.71e-03 | 95 | 73 | 3 | EFO_0007707 | |
| Disease | Hyperplasia | 2.19e-03 | 28 | 73 | 2 | C0020507 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.27e-03 | 105 | 73 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 2.28e-03 | 371 | 73 | 5 | EFO_0000275 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TQTTTHLQPLHHPSE | 821 | P35869 | |
| SQIHHPPQASVARHP | 1271 | Q96RT1 | |
| THTLQSHHHIPVVPA | 91 | Q99218 | |
| SHHHIPVVPAQQPRV | 96 | Q99218 | |
| HHSPRVPNSSVNQTE | 4256 | Q9NR09 | |
| VPHHCRQPETPTHAN | 3186 | Q7Z408 | |
| PQPAKPQQVIQHHHS | 1031 | O60885 | |
| LQSHDHHPPRANSRT | 396 | O76090 | |
| LVQTSPQDTSHQVHH | 126 | Q5JTZ5 | |
| QQQHHHLPTEALAPA | 1706 | P51610 | |
| HSHAHQHSPISPRTQ | 1851 | Q9Y618 | |
| AQPPEHSHLTQATVQ | 531 | O60309 | |
| PHPDQVQTQHSHLTR | 646 | O60309 | |
| HPNRIHISVQIPHQD | 3331 | Q86XX4 | |
| IRQSQQTLYHSHPPH | 286 | Q674X7 | |
| QPHVIHHTTVVQPNS | 161 | Q92567 | |
| AQPPEHSHLTQATVQ | 531 | A6NM11 | |
| PHPDQVQTQHSHLTR | 646 | A6NM11 | |
| AQPPEHSHLTQATVQ | 531 | A6NMS7 | |
| PHPDQVQTQHSHLTR | 646 | A6NMS7 | |
| PDPQHHSTLEQHPTA | 806 | Q9P107 | |
| VEDQHTPPQTAQHAR | 666 | Q7Z3E5 | |
| HISEHPNQQPSHKIQ | 4481 | Q2LD37 | |
| QRTVPQPVQSSHCHH | 851 | Q5VYM1 | |
| LDTPSQPVNNHHAHS | 126 | Q9NXR8 | |
| QPVNNHHAHSHTPVE | 131 | Q9NXR8 | |
| RHSQHQPPHLHFEEQ | 281 | A6NFC9 | |
| TSHFPQEKTHNHDPQ | 421 | Q8TE67 | |
| PSQNPTIHHQTAAAV | 1611 | Q8IZD2 | |
| APQPHRHVLEISRQH | 1266 | P50851 | |
| QGRETPHSHQPQHQD | 46 | Q9UI32 | |
| PHSHQPQHQDHDSSE | 51 | Q9UI32 | |
| HQHRQHSVPVISRPG | 796 | Q96M69 | |
| PQVVQTSPRHSPHHV | 211 | Q96FB5 | |
| HQHSHHPQQQLDIEP | 126 | Q9UBE8 | |
| QPHSLIKHQQIPLHS | 301 | Q8NDX5 | |
| HLQDAPNATSLHVPH | 6 | O95800 | |
| HITYVHQHSRQPPSQ | 536 | P33993 | |
| ETQQHIQLHVHEPPS | 1906 | Q96RW7 | |
| THHGVPLPQVSRHQE | 516 | Q9HBE1 | |
| VAHRIHHATPPQAQP | 291 | Q53HC0 | |
| RHLAARPPTQAQHQH | 436 | Q6P531 | |
| NTPSQHSHSIQHSPE | 256 | Q9NYF8 | |
| NILENTPENHPDHSH | 1391 | Q15811 | |
| QTQDHEHHHLRPPNR | 36 | P0DN25 | |
| SPHHTPKQESNAVHE | 166 | Q9NY43 | |
| HIHSSPCHERPNNVS | 1221 | Q9P267 | |
| DTQPNVLHNDPHARH | 36 | Q9NS00 | |
| HNNIVRCIVHSPTNP | 396 | Q05048 | |
| TQVPNHSLSHRQPET | 186 | P30260 | |
| QLLQHSTHSPHSPER | 121 | Q8TEX9 | |
| NSKPIHTTILNPHVH | 486 | Q13555 | |
| TIHNNHSVNIPVHQE | 511 | Q56UN5 | |
| APPHVIHHTTVVQPN | 111 | A1KXE4 | |
| QLEKNRLPSVHPHHS | 496 | O15294 | |
| QHHSPPVTQTIVLCH | 1176 | Q9BZA8 | |
| ERSPSVPNNQDHAHH | 786 | Q7Z2Y5 | |
| LQSVPLHHQVQPQAH | 356 | Q96NZ1 | |
| LHHQVQPQAHLAPDS | 361 | Q96NZ1 | |
| NNHINRVVSHPTLPV | 681 | Q13033 | |
| HLHQPHRVSQVLQVP | 1171 | Q8TEU7 | |
| SHPTIVSLHHQRPGQ | 81 | Q02363 | |
| SPHSQIHHSTPIRNQ | 271 | Q9UPW6 | |
| ENPRHFVDSHHQKPV | 181 | Q7KZF4 | |
| QTPPESHFQRKISHH | 1256 | Q6ZUB1 | |
| NRAPSPHVVQENLHS | 2916 | O75592 | |
| NSKPVHTTILNPHIH | 406 | Q9UQM7 | |
| IQAQPQHQDSHHITI | 41 | A0A1B0GV85 | |
| PPQPLHQVHRVQFVH | 31 | Q96KW2 | |
| RPSQPTHVNVHIHQE | 16 | Q3YBM2 | |
| PEHRQPPRLQHSQVH | 86 | O43597 | |
| ELHATTPVEHPNRNH | 2026 | Q8NFU7 | |
| SVAATHPTVQHPQGH | 516 | Q96EK2 | |
| IPHSHSVFRNPHRSQ | 151 | Q0P670 | |
| HTHHFPSPLSNNQEV | 116 | Q9HCN8 | |
| TSPHGALHQHVTDIQ | 281 | Q9UNN4 | |
| SLRPHSVVSPQHSHQ | 641 | Q8TEJ3 | |
| HDRMTEQHFPHPIQS | 146 | O15067 | |
| AHIVSNKVPVVQHPH | 181 | Q9NQB0 | |
| PHAESSVHSQPHNVH | 1496 | Q68DE3 | |
| SVHSQPHNVHQQRTL | 1501 | Q68DE3 | |
| HSQQLHPPSPTEHEV | 2541 | Q96JG9 | |
| PQHQSVITQRHPALA | 1061 | Q9ULD9 | |
| HLAEHQTTHPRQKPF | 146 | Q3KQV3 | |
| HHPESTPHQSKETQP | 511 | Q8N3L3 | |
| PQDLAPQVSAHHRSQ | 481 | Q9BXI6 | |
| QRSHLPHHQRVPTGE | 231 | Q02386 | |
| CHQHPPSHLTEVLQS | 91 | Q8TCH9 |